These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29782204)

  • 1. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
    Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
    FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.
    Borowczyk K; Shih DM; Jakubowski H
    J Alzheimers Dis; 2012; 30(2):225-31. PubMed ID: 22406444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
    Parada-Turska J; Wójcicka G; Beltowski J
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase.
    Borowczyk K; Tisończyk J; Jakubowski H
    Amino Acids; 2012 Sep; 43(3):1339-48. PubMed ID: 22227865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
    Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
    Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
    Jakubowski H
    Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the paraoxonase 1 gene affects the expression of mouse brain proteins involved in neurodegeneration.
    Suszyńska-Zajczyk J; Luczak M; Marczak L; Jakubowski H
    J Alzheimers Dis; 2014; 42(1):247-60. PubMed ID: 24844689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.
    Yilmaz N
    Arch Med Sci; 2012 Feb; 8(1):138-53. PubMed ID: 22457688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
    AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
    Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.
    Jamroz-Wiśniewska A; Bełtowski J; Wójcicka G; Bartosik-Psujek H; Rejdak K
    Oxid Med Cell Longev; 2020; 2020():1654754. PubMed ID: 32256946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells.
    Gurda D; Handschuh L; Kotkowiak W; Jakubowski H
    Amino Acids; 2015 Jul; 47(7):1319-39. PubMed ID: 25802182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
    Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
    FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
    Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
    FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease].
    Qin Q; Li YL; Zhao FM; Wang H; Li Y; Cui RZ; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):803-7. PubMed ID: 17217688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
    Jakubowski H; Ambrosius WT; Pratt JH
    FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial.
    Borowczyk K; Piechocka J; Głowacki R; Dhar I; Midtun Ø; Tell GS; Ueland PM; Nygård O; Jakubowski H
    J Intern Med; 2019 Feb; 285(2):232-244. PubMed ID: 30193001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.